• Login
    View Item 
    •   ResearchSpace Home
    • College of Agriculture, Engineering and Science
    • School of Life Sciences
    • Biotechnology
    • Biochemistry
    • Masters Degrees (Biochemistry)
    • View Item
    •   ResearchSpace Home
    • College of Agriculture, Engineering and Science
    • School of Life Sciences
    • Biotechnology
    • Biochemistry
    • Masters Degrees (Biochemistry)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Identifying small molecule binding ligands for the pup-ligase (PafA) of Mycobacterium tuberculosis.

    Thumbnail
    View/Open
    Mthembu_Sandile_Mehzi_2022.pdf (3.739Mb)
    Date
    2022
    Author
    Mthembu, Sandile Mehzi.
    Metadata
    Show full item record
    Abstract
    The rapid emergence of resistant TB strains (Mycobacterium tuberculosis (Mtb)) renders traditional treatment options ineffective and necessitates the generation of novel anti-TB drugs that possess innovative modes of action. The pup-ligase (PafA) of Mtb that solely mediates protein proteasomal removal via the pupylation cascade has recently been identified as a suitable target for TB drug development. A novel approach would be to recruit proteolysis targeting chimeras (PROTACs) technology as an alternative anti-TB treatment option by developing PROTAC-like molecules capable of recruiting the pupylation cascade. Therefore, the identification of novel PafA small-molecule binding ligands is an essential first step to establish possible new TB therapies. To this effect, PafA recombinant expression was successfully optimised in E. coli cells at 20°C for 20 h, where a 50-kDa protein was observed by sodium dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Moreover, the identity of the protein was confirmed via immunoblotting with anti-His antibodies and PafA subsequently purified via immobilized metal affinity chromatography (IMAC) to high purity. A thermal shift assay (TSA) of PafA against 48 small-molecule compounds from a chemical library pre-screened for non-specific inhibition activity was conducted. Seven Hit compounds were detected significantly binding PafA (P < 0.05), all inducing a > 5 °C increase of PafA melting temperature (Tm) upon binding. Future research on these novel PafA binding ligands will be to ascertain whether they possess inhibitor qualities. Additionally, they will be used in the synthesis of heterobifunctional molecules to create the first PROTAC-like molecules for targeted proteasomal degradation of essential Mtb proteins – a novel type of anti-TB drug.
    URI
    https://researchspace.ukzn.ac.za/handle/10413/21075
    Collections
    • Masters Degrees (Biochemistry) [131]

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV
     

     

    Browse

    All of ResearchSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsAdvisorsTypeThis CollectionBy Issue DateAuthorsTitlesSubjectsAdvisorsType

    My Account

    LoginRegister

    DSpace software copyright © 2002-2013  Duraspace
    Contact Us | Send Feedback
    Theme by 
    @mire NV